Suppr超能文献

镰刀菌属临床相关成员中的生物膜形成及对杀真菌剂的抗性

Biofilm Formation and Resistance to Fungicides in Clinically Relevant Members of the Fungal Genus Fusarium.

作者信息

Sav Hafize, Rafati Haleh, Öz Yasemin, Dalyan-Cilo Burcu, Ener Beyza, Mohammadi Faezeh, Ilkit Macit, van Diepeningen Anne D, Seyedmousavi Seyedmojtaba

机构信息

Department of Mycology, Kayseri Education and Research Hospital, Kayseri 38010, Turkey.

Department of Microbiology and Immunology, Center of Excellence for Infection Biology and Antimicrobial Pharmacology, Tehran 1969753491, Iran.

出版信息

J Fungi (Basel). 2018 Jan 23;4(1):16. doi: 10.3390/jof4010016.

Abstract

Clinically relevant members of the fungal genus, , exhibit an extraordinary genetic diversity and cause a wide spectrum of infections in both healthy individuals and immunocompromised patients. Generally, species are intrinsically resistant to all systemic antifungals. We investigated whether the presence or absence of the ability to produce biofilms across and within species complexes is linked to higher resistance against antifungals. A collection of 41 strains, obtained from 38 patients with superficial and systemic infections, and three infected crops, were tested, including 25 species within the species complex, 14 from the species complex (FSSC), one species complex, and one species complex isolate. Of all isolates tested, only seven strains from two species of FSSC, five . and two . strains, recovered from blood, nail scrapings, and nasal biopsy samples, could produce biofilms under the tested conditions. In the liquid culture tested, sessile biofilm-forming strains exhibited elevated minimum inhibitory concentrations (MICs) for amphotericin B, voriconazole, and posaconazole, compared to their planktonic counterparts, indicating that the ability to form biofilm may significantly increase resistance. Collectively, this suggests that once a surface adherent biofilm has been established, therapies designed to kill planktonic cells of are ineffective.

摘要

真菌属中与临床相关的成员表现出非凡的遗传多样性,并在健康个体和免疫功能低下的患者中引起广泛的感染。一般来说,某些物种对所有全身性抗真菌药物具有内在抗性。我们研究了在不同物种复合体中形成生物膜的能力的有无是否与对抗真菌药物的更高抗性有关。对从38例浅表和全身性感染患者以及三种感染作物中获得的41株菌株进行了测试,包括某物种复合体内的25个物种、来自另一物种复合体(FSSC)的14个物种、一个某物种复合体和一个某物种复合体分离株。在所有测试的分离株中,只有从血液、指甲刮屑和鼻活检样本中分离出的来自FSSC两个物种的七株菌株,五株某菌株和两株另一菌株,在测试条件下能够形成生物膜。在液体培养测试中,与浮游对应物相比,形成生物膜的固着菌株对两性霉素B、伏立康唑和泊沙康唑的最低抑菌浓度(MIC)升高,表明形成生物膜的能力可能显著增加抗性。总体而言,这表明一旦建立了表面附着的生物膜,旨在杀死某浮游细胞的治疗方法是无效的。

相似文献

2
Molecular Characterization and Antifungal Susceptibility of Clinical Species From Brazil.
Front Microbiol. 2019 Apr 10;10:737. doi: 10.3389/fmicb.2019.00737. eCollection 2019.
5
Activity of Amphotericin B Formulations and Voriconazole, Alone or in Combination, against Biofilms of and Fusarium spp.
Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0063821. doi: 10.1128/AAC.00638-21. Epub 2021 Aug 9.
6
Genotyping and In Vitro Antifungal Susceptibility Testing of Fusarium Isolates from Onychomycosis in India.
Mycopathologia. 2016 Aug;181(7-8):497-504. doi: 10.1007/s11046-016-0014-7. Epub 2016 May 2.
9
Efflux pump inhibition controls growth and enhances antifungal susceptibility of species complex.
Future Microbiol. 2020 Jan;15:9-20. doi: 10.2217/fmb-2019-0186. Epub 2020 Feb 11.
10
In vitro ability of Fusarium keratoplasticum to form biofilms in venous catheter.
Microb Pathog. 2022 Dec;173(Pt A):105868. doi: 10.1016/j.micpath.2022.105868. Epub 2022 Nov 5.

引用本文的文献

1
Cold atmospheric plasma improves antifungal responsiveness of Aspergillus flavus and Fusarium keratoplasticum conidia and mycelia.
PLoS One. 2025 Aug 11;20(8):e0326940. doi: 10.1371/journal.pone.0326940. eCollection 2025.
2
Fungal Biofilm: An Overview of the Latest Nano-Strategies.
Antibiotics (Basel). 2025 Jul 17;14(7):718. doi: 10.3390/antibiotics14070718.
4
5
The Hidden Fortress: A Comprehensive Review of Fungal Biofilms with Emphasis on .
J Fungi (Basel). 2025 Mar 19;11(3):236. doi: 10.3390/jof11030236.
6
In vivo and in vitro pathogenicity of Fusarium oxysporum and its biofilm components.
Braz J Microbiol. 2025 Jun;56(2):1061-1067. doi: 10.1007/s42770-025-01632-x. Epub 2025 Feb 17.
8
Fusarioid keratitis and other superficial infections: A 10-years prospective study from Northeastern Brazil.
PLoS Negl Trop Dis. 2024 Jun 17;18(6):e0012247. doi: 10.1371/journal.pntd.0012247. eCollection 2024 Jun.
9
DectiSomes: C-type lectin receptor-targeted liposomes as pan-antifungal drugs.
Adv Drug Deliv Rev. 2023 May;196:114776. doi: 10.1016/j.addr.2023.114776. Epub 2023 Mar 17.

本文引用的文献

1
Biofilm Formation by Species: A Comparative Study.
Front Microbiol. 2017 Aug 18;8:1568. doi: 10.3389/fmicb.2017.01568. eCollection 2017.
2
Inhibitory activity of hinokitiol against biofilm formation in fluconazole-resistant Candida species.
PLoS One. 2017 Feb 2;12(2):e0171244. doi: 10.1371/journal.pone.0171244. eCollection 2017.
3
Aspergillus flavus Keratitis: Experience of a Tertiary Eye Clinic in Turkey.
Mycopathologia. 2017 Apr;182(3-4):379-385. doi: 10.1007/s11046-016-0089-1. Epub 2016 Nov 8.
4
In vitro resistance of clinical Fusarium species to amphotericin B and voriconazole using the EUCAST antifungal susceptibility method.
Diagn Microbiol Infect Dis. 2016 Aug;85(4):438-43. doi: 10.1016/j.diagmicrobio.2016.05.006. Epub 2016 May 12.
5
Virulence Attributes and Antifungal Susceptibility Profile of Opportunistic Fungi Isolated from Ophthalmic Infections.
Mycopathologia. 2016 Oct;181(9-10):653-61. doi: 10.1007/s11046-016-0018-3. Epub 2016 May 18.
6
Genotyping and In Vitro Antifungal Susceptibility Testing of Fusarium Isolates from Onychomycosis in India.
Mycopathologia. 2016 Aug;181(7-8):497-504. doi: 10.1007/s11046-016-0014-7. Epub 2016 May 2.
7
Fusarium: Molecular Diversity and Intrinsic Drug Resistance.
PLoS Pathog. 2016 Apr 7;12(4):e1005464. doi: 10.1371/journal.ppat.1005464. eCollection 2016 Apr.
8
Challenges in Fusarium, a Trans-Kingdom Pathogen.
Mycopathologia. 2016 Apr;181(3-4):161-3. doi: 10.1007/s11046-016-9993-7. Epub 2016 Mar 10.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验